«Zero Bleeds» – realistisches Behandlungsziel bei Hämophilie A

IF 1.9 4区医学 Q3 HEMATOLOGY Transfusion Medicine and Hemotherapy Pub Date : 2021-10-01 DOI:10.1159/000519809

Amy L. Dunn

引用次数: 0

Abstract

information@karger.com www.karger.com eignisse mehr hatten [2] und diese Patienten insgesamt über eine bessere Lebensqualität berichteten [3]. Aus Sicht der erfahrenen Hämostaseologin ist eine Blutungsfreiheit («Zero Bleeds») ein realistisches Therapieziel, das Hämophilie-A-Patienten und das Behandlungsteam unbedingt anstreben sollten, weil es die Lebensqualität von Patienten mit Hämophilie A deutlich verbessern kann.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

无Bleeds«»,脚踏实地Behandlungsziel在血友病A

information@karger.comwww.karger.com事件有更多[2]，这些患者总体上报告了更好的生活质量[3]。在这位经验丰富的止血专家看来，零出血是血友病a患者和治疗团队应该努力实现的现实治疗目标，因为它可以显著提高血友病a患者的生活质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Transfusion Medicine and Hemotherapy 医学-免疫学

CiteScore

4.00

自引率

9.10%

发文量

审稿时长

6-12 weeks

期刊介绍： This journal is devoted to all areas of transfusion medicine. These include the quality and security of blood products, therapy with blood components and plasma derivatives, transfusion-related questions in transplantation, stem cell manipulation, therapeutic and diagnostic problems of homeostasis, immuno-hematological investigations, and legal aspects of the production of blood products as well as hemotherapy. Both comprehensive reviews and primary publications that detail the newest work in transfusion medicine and hemotherapy promote the international exchange of knowledge within these disciplines. Consistent with this goal, continuing clinical education is also specifically addressed.

期刊最新文献

Erratum. Autoimmune Hemolytic Anemias: Challenges in Diagnosis and Therapy. Classical Haematology: Dynamic Development at the Interface of Transfusion Medicine and Haematology. Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment. Sickle Cell Disease.